Bixiye
QP22-18 Updated Government Programs Prior Authorization List
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 05, 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 3001 - 3010 ee natiijooyinka 3289
Bixiye
P13-18 Commercial and FEP Business New Reimbursement Policy for Facility: Readmission
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018
Bixiye
P12-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective June 4, 2018
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018
Bixiye
P2R1-18 Updated: New Medical Drug Prior Authorization Requirements for Voretigene Neparvovec (Luxturna)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018
Bixiye
P11-18 Minnesota Health Care Programs (MHCP) Reimbursement Rate for Vaccine Administration
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018
Bixiye
2018 April Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018
Bixiye
QP21-18 Availity Referral Portal Functionality Updates
Taariikhda uu dhaqangalayo Barnaamijka: Mar 28, 2018
Bixiye
QP20-18 Identification Numbers for Zenith American Solutions Funds
Taariikhda uu dhaqangalayo Barnaamijka: Mar 26, 2018
Bixiye
QP19-18 Changes to the Blue Cross Provider Website - One Medical Policy Library
Taariikhda uu dhaqangalayo Barnaamijka: Mar 13, 2018
Bixiye
QP18-18 Medical Drug Exclusion Lists Expanded to Include Ixifi, Durolane, Visco 3 and TriVisc
Taariikhda uu dhaqangalayo Barnaamijka: Mar 08, 2018